Trauma! Massive Transfusion

aka Trauma Tribulation 026

The unfortunate scaffolder from Trauma Tribulation 025 is still in extremis, he is bleeding from multiple sites and is in hemorrhagic shock. The trauma team is hard at work and the operating theatre staff are preparing for his arrival. He is being actively resuscitated…

A lot has changed in recent years, with the rise of damage control resuscitation and the development of massive transfusion protocols. If you’re the Trauma Team Leader (and, in this case, you are!) you’d better know all the ins and outs.


Questions

Q1. When should a massive transfusion protocol be triggered?

Answer and interpretation

The simplest trigger is when a senior clinician suspects impending or actual hemorrhagic shock in bleeding patient.

Various scoring systems have been developed to predict the need for massive transfusion, such as the ABC score, the TASH score and the McLaughlin score

There is also research that methods such as thromboelastometry can give an early warning of acute coagulopathy of trauma/ shock (ACoTS).

Assessment of Blood Consumption (ABC) score

  • ED SBP <90mmHg(0=no; 1=yes)
  • ED HR >120bpm
  • Penetrating mechanism
  • Positive fluid on FAST exam

Score of 3 predicts 45% need for massive transfusion; score of 4 predicts 100% need for massive transfusion

Trauma-Associated Severe Hemorrhage

  • SBP
  • Gender
  • Hb
  • Fluid on ultrasound
  • HR
  • Base excess
  • Extremity or pelvic fracture

McLaughlin score

  • HR > 105/min
  • SBP < 110 mmHg
  • pH < 7.25
  • Hct < 32%

Q2. What is the definition of massive transfusion?

Answer and interpretation

Definitions vary… They include:

  • 10 unit transfusion in 24 h
  • transfusion of an entire blood volume in 24 h
  • replacement of 50% blood volume over 3 h

Up to 5% of civilian trauma patients require massive transfusion, and of these 25% have trauma-associated coagulopathy on assessment in ED.


Q3. What ‘essential’ history is required when activating the massive transfusion protocol?

Answer and interpretation
  • Age, gender, mechanism of injury
  • Blood components given pre-hospital
  • FFP and platelets are likely to be needed earlier if the patient has been transfused pre-hospital
  • Known bleeding diathesis
  • Bleeding disorders and coagulopathies
  • Drugs, e.g. warfarin, aspirin and clopidogrel
  • History of previous transfusions, antibodies, reactions if known

Q4. What is the general guide to blood component therapy until major haemorrhage is controlled?

Answer and interpretation

Administer a 1:1:1 ratio of red cells, FFP and platelets

This ratio of blood products emulates the composition of whole blood. The target is to achieve 1:1:1 ratio over 6 hours.

The protocol I’m most familiar with involves:

  • Activation of massive transfusion protocol (includes alerting the hematologist on call and laboratory staff)
  • Send blood tests: cross match, coags, FBC, blood gas (including iCa)
  • Give initial major hemorrhage pack (4 units PRBCS and 2 units thawed FFP)
  • In the presence of ongoing uncontrolled haemorrhage give alternating packs A and B, with repeat blood tests after each pack:
    — Pack A: 2 units PRBC, 2 units FFP, 1 adult bag of platelets
    — Pack B: 2 units PRBC, 2 units FFP

Note that 1 adult bag of platelets is equivalent to 4 units PRBCs for the purposes of maintaining the 1:1 ratio.

Note that the 1:1:1 concept is mainly supported by the fact that it makes sense pathophysiologically and by retrospective and observational studies. It has not been conclusively proven in the way that a large double-blind randomised controlled trial would. Indeed, there are concerns that at least some of the perceived benefit of hemostatic resuscitation and the ‘1:1:1’ ratio is due to survivor bias. Cliff Reid states this eloquently:

“In some circles, ‘wuntwuntwun’ is in danger of becoming the new dogma of trauma fluid replacement (ie. 1 unit of plasma and 1 unit of platelets for every unit of red cells). Since it takes longer to thaw some plasma than it does to throw in some O negative packed red cells, some really sick patients may be dead before they get the plasma, biasing comparisons that show a reduced mortality in patients who were still alive to receive plasma. This ‘survivor bias’ has been suggested as a reason that high plasma:red cell ratios are associated with mortality reduction, although this has been challenged.”

Learn more:


Q5. What is the role of tranexamic acid in patients with major trauma?

Answer and interpretation

Current Australian guidelines advise that tranexamic acid should be considered in trauma patients with, or at risk of, significant haemorrhage.

Tranexamic acid an antifibrinolytic that works by competitively inhibiting the activation of plasminogen to plasmin  plasmin is responsible for the degradation of fibrin. Given that tranexamic acid is cheap, one of the few interventions with proven mortality benefit (NNT = 67) and few adverse effects I think clinicians should strongly consider this using this agent in major trauma patients.

Tranexamic acid is given as 1g IV loading dose followed by 1g over 8 hours. It should be given with 3 hours of major trauma.

Tranexamic acid should be given early, within 3 hours of the time of injury.

Learn more:


Q6. What specific blood component interventions may be initiated, and what should trigger their administration?

Answer and interpretation

Again, based on the protocol with which I am most familiar:

Platelets

  • Give platelets 1 adult dose if platelets <50 x 10E9/L

FFP

  • Give FFP 4 units if INR > 1.5 or APTT >50

Cryoprecipitate

  • Give cryoprecipitate 8 units if fibrinogen <1.o g/L

Calcium

  • Give 10% calcium chloride 10 mL if ionized calcium <1.1 mmol/L

The main difference in the Australian National Blood Authority guidelines is that FFP 15 mL/kg is recommended rather than 4 units.


Q7. What is the role of recombinant factor VIIa?

Answer and interpretation

Recombinant Factor VIIa may be considered for use in consultation with a hematologist if there is:

  • Uncontrolled haemorrhage
  • That is not amenable to surgical or interventional radiological therapies
  • In a salvageable patient with
    — optimal blood component therapy (INR, APTT, platelets and fibrinogen all in the normal range),
    — pH 7.2, and
    — normothermia (T>34C)

Factor VIIa is dosed at 100 mcg/kg to the nearest vial. Further blood component therapy can be given according to serial blood test results.

Remember that Factor VIIa is very expensive and has not been proven to affect clinically meaningful outcomes in the setting of major haemorrhage.


References

Journal Articles and Textbooks

  • Cap AP, Baer DG, Orman JA, Aden J, Ryan K, Blackbourne LH. Tranexamic acid for trauma patients: a critical review of the literature. J Trauma. 2011 Jul;71(1 Suppl):S9-14. Review. PubMed PMID: 21795884.
  • Crash-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.Lancet. 2010 Jul 3;376(9734):23-32. Pubmed PMID: 20554319 [fulltext]
  • CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011 Mar 26;377(9771):1096-101, 1101.e1-2. PubMed PMID: 21439633.
  • Fildes J, et al. Advanced Trauma Life Support Student Course Manual (8th edition), American College of Surgeons 2008.
  • Legome E, Shockley LW. Trauma: A Comprehensive Emergency Medicine Approach, Cambridge University Press, 2011.
  • Marx JA, Hockberger R, Walls RM. Rosen’s Emergency Medicine: Concepts and Clinical Practice (7th edition), Mosby 2009. [mdconsult.com]
  • McLaughlin DF, Niles SE, Salinas J, Perkins JG, Cox ED, Wade CE, Holcomb JB. A predictive model for massive transfusion in combat casualty patients. J Trauma. 2008 Feb;64(2 Suppl):S57-63; discussion S63. PubMed PMID: 18376173.
  • Nunez TC, Voskresensky IV, Dossett LA, Shinall R, Dutton WD, Cotton BA. Early prediction of massive transfusion in trauma: simple as ABC (assessment of blood consumption)? J Trauma. 2009 Feb;66(2):346-52. PubMed PMID: 19204506.
  • Yücel N, Lefering R, Maegele M, Vorweg M, Tjardes T, Ruchholtz S, Neugebauer EA, Wappler F, Bouillon B, Rixen D; Polytrauma Study Group of the German Trauma Society. Trauma Associated Severe Hemorrhage (TASH)-Score: probability of mass transfusion as surrogate for life threatening hemorrhage after multiple trauma. J Trauma. 2006 Jun;60(6):1228-36; discussion 1236-7. PubMed PMID: 16766965.

Social Media and Web Resources


Trauma Tribulation back

CLINICAL CASES

Trauma Tribulation

Chris is an Intensivist and ECMO specialist at the Alfred ICU in Melbourne. He is also the Innovation Lead for the Australian Centre for Health Innovation at Alfred Health, a Clinical Adjunct Associate Professor at Monash University, and the Chair of the Australian and New Zealand Intensive Care Society (ANZICS) Education Committee. He is a co-founder of the Australia and New Zealand Clinician Educator Network (ANZCEN) and is the Lead for the ANZCEN Clinician Educator Incubator programme. He is on the Board of Directors for the Intensive Care Foundation and is a First Part Examiner for the College of Intensive Care Medicine. He is an internationally recognised Clinician Educator with a passion for helping clinicians learn and for improving the clinical performance of individuals and collectives.

After finishing his medical degree at the University of Auckland, he continued post-graduate training in New Zealand as well as Australia’s Northern Territory, Perth and Melbourne. He has completed fellowship training in both intensive care medicine and emergency medicine, as well as post-graduate training in biochemistry, clinical toxicology, clinical epidemiology, and health professional education.

He is actively involved in in using translational simulation to improve patient care and the design of processes and systems at Alfred Health. He coordinates the Alfred ICU’s education and simulation programmes and runs the unit’s education website, INTENSIVE.  He created the ‘Critically Ill Airway’ course and teaches on numerous courses around the world. He is one of the founders of the FOAM movement (Free Open-Access Medical education) and is co-creator of litfl.com, the RAGE podcast, the Resuscitology course, and the SMACC conference.

His one great achievement is being the father of two amazing children.

On Twitter, he is @precordialthump.

| INTENSIVE | RAGE | Resuscitology | SMACC

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.